No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
521 |
4. Check minimum number of eventsNone |
521 |
5. Include endpointsNone |
521 |
6. Filter based on genotype QC (FinnGen only) |
521 |
Control definitions (FinnGen only)
- Control exclude
- AB1_INTESTINAL_INFECTIONS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Other protozoal intestinal diseases
based on the number of shared cases.
Similar with more cases:
- Intestinal infectious diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4130 | 2179 | 1912 |
| Only index persons | 3443 | 1892 | 1551 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.05 |
| Only index persons | 0.06 | 0.07 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 32.48 | 34.90 | 29.57 |
| Only index persons | 34.41 | 35.94 | 32.55 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 521 | 327 | 194 |
| Unadjusted period prevalence (%) | 0.10 | 0.11 | 0.09 |
| Median age at first event (years) | 44.84 | 42.69 | 48.47 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 452
- Matched controls
- 4520
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A07.8
ICD-10 Finland
Other specified protozoal intestinal diseases
+∞
199.1
176
*
A07.1
ICD-10 Finland
Giardiasis [lambliasis]
+∞
115.7
106
*
P01AB01
ATC
metronidazole; oral, rectal
6.2
70.4
307
1155
A07.9
ICD-10 Finland
Protozoal intestinal disease, unspecified
+∞
69.6
65
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
8.6
54.5
130
202
00710
ICD-8 Finland
Other protozoal intestinal diseases, Giardiasis
+∞
47.8
45
*
A07.2
ICD-10 Finland
Cryptosporidiosis
+∞
30.6
29
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
17.3
145
671
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
17.2
195
1070
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
46.7
15.2
18
*
A02BC05
ATC
esomeprazole; systemic
2.3
15.0
195
1122
K59.1
ICD-10 Finland
Functional diarrhoea
5.8
14.8
42
78
D11
ICPC
Diarrhoea
3.2
13.8
80
287
UJF32
NOMESCO Finland
Coloscopy
2.5
13.3
117
546
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
4.5
13.1
47
114
00799
ICD-8 Finland
Other protozoal intestinal diseases, Other and unspecified
+∞
12.6
12
*
UJF30
NOMESCO Finland
Ileoscopy through colon
3.5
12.5
61
194
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.8
10.6
71
280
0071A
ICD-9 Finland
Other protozoal intestinal diseases, Giardiasis
+∞
10.5
10
*
Z2221
NOMESCO Finland
Medical doctor
2.1
10.4
147
847
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
4.8
9.8
32
71
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
102.1
9.4
10
*
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
+∞
9.4
9
*
R53
ICD-10 Finland
Malaise and fatigue
2.3
9.2
96
478
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
9.1
116
634
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.8
8.8
28
61
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
8.4
104
561
A06
ICD-10 Finland
Amoebiasis
+∞
8.4
8
*
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
+∞
8.4
8
*
E0000UV
ATC
NA
1.8
8.3
183
1221
D01
ICPC
Abdominal pain/cramps general
2.5
8.2
65
284
H04.10
ICD-10 Finland
Dry eye syndrome
2.7
7.6
51
200
A04
ICPC
Weakness/tiredness general
2.4
7.5
65
296
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.7
7.4
50
197
A06.8
ICD-10 Finland
Amoebic infection of other sites
+∞
7.3
7
*
A06.9
ICD-10 Finland
Amoebiasis, unspecified
+∞
7.3
7
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
7.3
171
1153
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.3
6.9
64
300
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
6.9
107
625
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.8
6.8
43
163
A02BA02
ATC
ranitidine; systemic
2.1
6.8
78
403
J01MA06
ATC
norfloxacin; oral
2.3
6.7
65
312
Z71.8
ICD-10 Finland
Other specified counselling
1.9
6.7
114
689
C10AC01
ATC
colestyramine; oral
5.3
6.7
19
37
J02AC01
ATC
fluconazole; systemic
1.7
6.7
180
1257
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
6.7
75
384
A02BC01
ATC
omeprazole; systemic
1.8
6.5
114
698
A06AD11
ATC
lactulose; oral
2.4
6.4
54
245
ZXE00
NOMESCO Finland
One hour or less
1.7
6.3
178
1259
00000
ICD-8 Finland
NA
+∞
6.3
6
*
0078A
ICD-9 Finland
Other protozoal intestinal diseases, Other specified protozoal intestinal diseases[CRYPTOSPORIDIOSIS]
+∞
6.3
6
*
A07.0
ICD-10 Finland
Balantidiasis
+∞
6.3
6
*
Z3231
NOMESCO Finland
Registered nurse
1.8
6.1
124
791
K30
ICD-10 Finland
Functional dyspepsia
2.4
6.1
51
229
N02CC04
ATC
rizatriptan; oral
3.0
6.0
32
111
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003327) Ova and parasites identified in Stool by Light microscopy
273
131
42.68
307.65
4.3
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
204
527
5.72
78.75
2.4
2.4
ug/g
76.7
98.4
1.06
168
407
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
55
27
22.66
73.31
2.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
55
28
21.84
72.18
2.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
116
204
7.03
66.27
1.8
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
80
111
8.33
56.25
1.4
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
80
113
8.18
55.37
1.4
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
80
114
8.11
54.95
1.4
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
103
205
6.02
51.32
1.5
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
138
420
4.11
40.51
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
97
227
5.02
39.86
1.5
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
29
13
23.56
39.62
2.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
28
13
22.70
37.69
2.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
223
996
3.17
35.35
1.5
1.3
u/ml
2.8
2.1
0.15
35
252
(42870588) Differential panel, method unspecified - Blood
270
1359
3.05
34.41
4.9
6.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
56
94
6.55
32.71
1.6
1.3
ug/g
303.6
310.1
0.07
40
47
(3007164) IgA [Mass/volume] in Serum or Plasma
203
916
2.99
30.80
1.7
1.4
g/l
2.1
2.3
0.89
102
569
(40768797) Stomach Pathology biopsy report
133
484
3.35
29.02
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
109
361
3.55
27.49
1.2
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
345
2162
2.76
26.46
5.8
5.9
e9/l
2.1
2.0
0.25
286
1923
(3001604) Monocytes [#/volume] in Blood
336
2092
2.71
25.86
5.9
5.9
e9/l
0.5
0.6
0.44
269
1823
(3018010) Neutrophils/100 leukocytes in Blood
326
2009
2.66
25.47
5.9
5.8
%
53.9
56.7
4.24
310
1893
(3022096) Basophils/100 leukocytes in Blood
314
1901
2.64
25.44
6.1
6.1
%
0.7
0.7
1.40
295
1779
(3002030) Lymphocytes/100 leukocytes in Blood
328
2031
2.66
25.32
6.2
6.0
%
31.0
28.9
3.20
312
1907
(3006315) Basophils [#/volume] in Blood
335
2103
2.66
25.01
5.9
5.9
e9/l
0.0
0.0
0.32
269
1834
(3006504) Eosinophils/100 leukocytes in Blood
318
1960
2.60
24.45
6.2
6.0
%
3.2
2.8
1.36
300
1836
(3019069) Monocytes/100 leukocytes in Blood
319
1970
2.60
24.42
6.4
6.2
%
8.5
8.4
0.47
300
1856
(3013115) Eosinophils [#/volume] in Blood
339
2180
2.59
23.42
6.0
6.2
e9/l
0.2
0.2
0.57
280
1930
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
101
355
3.29
22.93
1.9
2.3
u/l
29.6
34.9
0.71
91
308
(3013650) Neutrophils [#/volume] in Blood by Automated count
359
2397
2.60
22.50
7.6
9.0
e9/l
3.6
4.0
3.27
292
2102
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
36
65
5.88
19.41
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
291
1874
2.25
18.17
8.6
9.1
e9/l
0.0
0.0
0.30
205
1522
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
74
251
3.27
17.60
1.1
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
185
999
2.32
17.57
2.4
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
408
3071
2.51
17.03
7.8
6.8
u/l
71.3
78.9
2.76
388
2867
(3024561) Albumin [Mass/volume] in Serum or Plasma
252
1572
2.17
16.54
4.4
4.5
g/l
36.5
36.2
0.39
236
1479
(40758558) Short blood count panel - Blood
185
1020
2.26
16.54
5.6
6.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
74
262
3.13
16.36
1.5
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
187
1047
2.23
16.01
2.5
2.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
36
79
4.82
15.64
1.8
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
238
1480
2.12
15.46
2.2
1.8
pmol/l
95.7
95.5
0.02
129
787
(3018095) Leukocytes [#/volume] in Urine
230
1417
2.12
15.26
3.4
3.4
e6/l
23.3
69.4
2.99
140
942
(3030467) Casts [#/volume] in Urine by Automated count
186
1065
2.16
14.85
2.9
2.8
e6/l
0.2
0.4
1.35
124
774
(3020961) Endomysium IgA Ab [Titer] in Serum
64
236
2.95
13.11
1.2
1.2
titre
—
147.0
—
0
8
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
97
455
2.39
12.26
2.4
2.8
umol/l
7.0
6.7
0.08
80
395
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
284
1992
1.94
12.20
5.9
6.0
umol/l
11.5
10.8
0.64
269
1889
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
211
1361
1.92
11.47
3.0
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
188
1167
1.96
11.45
2.9
3.0
e6/l
43.1
64.4
0.50
129
863
(3013707) Erythrocyte sedimentation rate by Westergren method
387
3090
1.98
10.45
4.5
3.8
mm/h
8.3
10.8
4.65
368
2854
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
118
646
2.07
10.08
2.6
2.6
e6/l
0.4
0.9
4.04
56
362
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
119
657
2.05
9.92
2.8
2.7
mmol/l
2.4
2.4
1.73
100
580
(3001122) Ferritin [Mass/volume] in Serum or Plasma
267
1938
1.77
9.35
3.9
2.8
ug/l
80.7
101.3
1.86
250
1809
(3036071) Salmonella sp Ab [Titer] in Serum
13
17
7.82
9.31
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
155
957
1.88
9.26
2.8
2.1
mg/l
2.5
3.0
1.67
137
814
(3024980) IgG subclass 4 [Mass/volume] in Serum
25
63
4.12
9.15
2.3
1.5
g/l
1.0
0.6
0.78
20
48
(3000850) Epithelial cells [#/volume] in Urine
131
772
1.93
8.99
2.1
2.3
e6/l
6.1
6.7
0.13
109
667
(3018418) pH of Serum or Plasma
171
1099
1.83
8.95
3.2
3.5
ph
7.4
7.4
0.66
23
197
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
47
181
2.76
8.86
2.4
2.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
231
1634
1.74
8.65
2.1
2.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
22
53
4.29
8.53
2.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
53
4.29
8.53
2.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
22
53
4.29
8.53
2.0
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
480
4257
2.62
8.52
15.2
11.7
mg/l
19.9
21.7
0.62
362
3267
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
54
4.21
8.34
2.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
22
54
4.21
8.34
2.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
22
54
4.21
8.34
2.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
38
135
2.96
8.30
1.3
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
235
1686
1.72
8.25
2.5
2.2
nmol/l
80.1
75.3
1.66
206
1532
(3015377) Calcium [Moles/volume] in Serum or Plasma
191
1299
1.74
8.09
2.7
2.9
mmol/l
2.3
2.4
0.25
168
1149
(3037467) Urinalysis macro (dipstick) panel - Urine
358
2894
1.76
8.02
5.0
3.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
104
594
1.94
7.73
2.6
2.2
umol/l
14.8
13.9
0.41
98
548
(3005719) IgG [Mass/volume] in Serum or Plasma
67
325
2.22
7.71
2.9
2.6
g/l
11.1
10.1
1.18
56
299
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
107
620
1.91
7.62
2.7
2.8
e6/l
1.2
2.4
2.67
47
340
(3002385) Erythrocyte distribution width [Ratio]
428
3687
1.90
7.31
17.5
14.4
%
13.3
13.5
2.05
422
3629
(3009542) Hematocrit [Volume Fraction] of Blood
458
4042
2.10
7.22
16.1
12.8
%
40.6
40.1
1.22
384
3129
(3032773) Endomysium IgG Ab [Titer] in Serum
18
43
4.30
7.06
1.1
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
248
1857
1.64
7.06
5.4
6.7
mmol/l
1.2
1.2
0.08
221
1578
(3021960) Folate [Moles/volume] in Serum or Plasma
135
860
1.77
7.04
1.5
1.5
nmol/l
22.7
21.4
0.50
124
742
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
448
3932
1.99
7.03
13.1
10.6
ml/min/173m2
87.9
85.7
1.44
360
3142
(3004789) Transferrin [Mass/volume] in Serum or Plasma
95
544
1.91
6.97
2.6
2.1
g/l
2.3
2.4
0.74
87
500
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
368
3071
1.68
6.57
4.2
3.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
88
501
1.91
6.56
2.8
2.2
%
26.0
23.2
0.71
80
436
(3026782) Osmolality of Urine
118
738
1.77
6.50
2.8
2.6
mosm/kgh2o
554.1
564.0
0.17
91
622
(3011397) Hemoglobin [Presence] in Urine by Test strip
141
928
1.71
6.49
3.2
3.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
227
1691
1.61
6.42
4.4
6.1
mmol/l
1.2
1.2
0.19
216
1541
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
445
3928
1.91
6.41
5.4
4.5
mu/l
1.7
2.1
0.75
423
3626
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
77
3.22
6.24
1.1
1.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
17
43
4.05
6.21
1.5
1.3
g/l
2.4
2.7
0.24
12
31
(3024139) IgG subclass 3 [Mass/volume] in Serum
17
43
4.05
6.21
1.5
1.3
g/l
0.3
0.4
0.33
12
30
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
388
3306
1.68
6.15
4.4
3.8
pmol/l
14.4
14.6
0.75
360
3032
(4062490)
17
45
3.87
5.85
1.6
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
137
917
1.67
5.85
1.8
1.9
mg/l
1.6
1.1
0.60
100
697
(3019550) Sodium [Moles/volume] in Serum or Plasma
470
4264
2.04
5.68
15.2
13.1
mmol/l
139.5
139.7
1.11
464
4139
(3044889) 12 lead EKG panel
333
2773
1.56
5.42
3.6
3.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
470
4280
2.00
5.37
15.6
13.2
mmol/l
3.9
3.9
7.61
464
4147
(3028026) IgM [Mass/volume] in Serum or Plasma
53
272
2.06
5.29
1.8
1.7
g/l
1.2
1.4
0.67
47
254
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
64
3.21
5.24
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
62
339
1.94
5.19
1.4
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
106
687
1.68
5.06
3.3
3.6
ng/l
1404.6
364.4
0.37
73
489
(3051651) Icteric interference index of Serum or Plasma
10
19
5.35
5.06
2.4
2.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
139
968
1.59
4.98
1.6
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
68
390
1.86
4.93
3.4
4.8
u/l
228.1
241.7
0.67
63
374
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
7
11.58
4.80
1.3
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
34
152
2.32
4.77
1.9
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
37
172
2.24
4.75
2.0
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
184
1383
1.51
4.63
3.3
3.0
u/l
33.0
29.7
0.44
176
1324
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
24
95
2.60
4.36
1.8
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
24
98
2.52
4.11
1.2
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
14
6.52
4.00
1.6
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
14
6.52
4.00
1.6
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
159
1193
1.48
3.93
3.0
2.3
u/l
56.0
57.7
0.24
149
1107
(3020874) Milk IgE Ab [Units/volume] in Serum
11
29
3.85
3.82
1.3
1.2
u/ml
0.1
1.4
—
6
11
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
107
745
1.55
3.75
1.2
1.3
iu/ml
31.1
35.9
0.17
23
236
(4035726)
54
315
1.80
3.73
1.7
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
53
308
1.80
3.70
3.8
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
12
6.75
3.68
1.6
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
12
6.75
3.68
1.6
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
30
3.72
3.65
2.5
2.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
20
80
2.56
3.59
1.2
1.0
u/ml
1.0
2.3
—
8
39
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
64
397
1.70
3.58
3.8
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
100
694
1.55
3.55
3.3
2.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
93
2.43
3.53
1.2
1.4
u/ml
245.3
240.8
0.02
13
51
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
13
6.23
3.51
1.1
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
48
277
1.81
3.44
1.2
1.2
u/ml
210.4
159.0
0.35
41
249
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
91
626
1.55
3.36
3.1
1.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
246
2048
1.38
3.28
5.5
4.5
estimate
0.0
0.0
0.50
42
398
(3052851) Hemolysis interference index of Serum or Plasma
23
103
2.29
3.27
2.9
2.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
29
144
2.07
3.22
1.5
2.5
g/l
1.2
1.3
0.32
23
126
(3009261) Glucose [Presence] in Urine by Test strip
247
2069
1.37
3.12
3.8
3.3
estimate
0.0
0.0
0.50
41
384
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
141
1075
1.43
3.12
1.6
1.6
mmol/l
1.1
1.4
4.81
118
911
(3000492) Spirometry study
62
396
1.64
3.12
1.4
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
101
723
1.49
3.09
1.2
1.3
u/ml
5.5
11.5
0.71
33
272
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
56
349
1.68
3.09
3.1
2.4
g/l
0.2
0.2
0.34
51
331
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
168
1.96
3.07
1.2
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
165
1297
1.40
3.06
2.2
2.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
243
2038
1.36
3.01
3.8
3.2
estimate
0.0
0.0
0.00
38
392
(3037522) Nuclear Ab [Titer] in Serum
85
591
1.52
2.99
1.4
1.4
titre
378.7
408.6
0.10
15
116
(3027945) Reticulocytes/100 erythrocytes in Blood
60
385
1.63
2.97
2.1
3.2
%
1.5
1.7
2.08
51
353
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
6
9
6.73
2.87
2.8
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
44
263
1.74
2.83
3.1
3.3
pmol/l
4.5
4.6
0.34
35
231
(3000093) Morphology [Interpretation] in Blood Narrative
11
36
3.10
2.82
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
18
4.50
2.80
1.0
1.2
nmol/l
166.9
147.7
—
8
18
(3019309) Folate [Moles/volume] in Red Blood Cells
88
626
1.49
2.78
1.9
1.7
nmol/l
1072.4
1169.0
0.47
62
477
(3000494) Fungus identified in Specimen by Culture
70
475
1.55
2.75
1.4
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
66
2.47
2.73
1.2
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
119
2.07
2.70
1.2
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
266
2290
1.33
2.66
4.1
4.6
mmol/l
6.2
6.6
2.36
249
2094
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
20
95
2.15
2.52
1.1
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
77
544
1.49
2.52
2.1
1.5
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
8
21
3.85
2.47
1.4
1.2
umol/l
20.8
23.4
—
8
21
(3036481) Cortisol [Moles/volume] in Serum or Plasma
60
404
1.55
2.45
1.8
2.0
nmol/l
374.6
371.8
0.04
54
378
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
34
2.98
2.42
1.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
27
3.37
2.40
3.2
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
17
4.16
2.36
1.1
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
127
996
1.36
2.33
2.2
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
72
2.26
2.30
1.4
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
78
565
1.45
2.26
1.7
2.4
s
30.3
29.5
0.85
78
554
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
323
2898
1.30
2.22
3.7
2.9
u/l
39.9
42.5
0.21
304
2737
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
229
1965
1.30
2.22
3.6
3.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
45
291
1.60
2.20
1.9
2.5
e9/l
3.9
4.0
0.12
38
235
(3025130) Human papilloma virus identified in Specimen
15
67
2.28
2.19
2.3
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
19
94
2.06
2.18
1.3
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
14
4.32
2.15
1.2
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
118
926
1.35
2.15
4.1
3.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
335
1.54
2.11
1.1
1.2
iu/ml
137.8
166.7
0.14
11
148
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
43
2.59
2.11
1.1
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
11
43
2.59
2.11
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
43
2.59
2.11
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
43
2.59
2.11
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
31
2.94
2.08
2.4
2.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
104
804
1.37
2.08
1.3
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
10
5.04
2.07
1.0
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
73
532
1.43
2.05
1.6
1.8
%
1.2
1.4
2.36
61
483
(40767503) Oxygen content in Capillary blood by calculation
14
63
2.26
2.02
2.4
2.5
%
17.3
16.2
—
8
36
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
44
2.53
2.02
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
44
2.53
2.02
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
44
2.53
2.02
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
26
3.11
2.02
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
474
4529
1.52
2.00
11.8
9.3
u/l
24.4
26.0
1.74
467
4377
(3012501) Base excess in Blood by calculation
15
70
2.18
2.00
4.1
2.7
mmol/l
2.5
2.8
—
8
41
(3044290) Cell count panel - Cerebral spinal fluid
17
84
2.06
1.97
1.2
2.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
120
956
1.33
1.97
2.7
3.0
ng/l
748.4
1197.4
1.76
91
813
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
21
3.36
1.97
1.4
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
11
4.58
1.94
1.2
2.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
121
1.85
1.91
1.2
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
49
335
1.51
1.90
2.8
4.4
ug/l
3.3
20.3
0.74
34
275
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
135
1099
1.31
1.90
2.3
2.0
u/l
130.4
272.7
1.52
126
1029
(40758292) HTLV I+II Ab panel - Serum
5
12
4.20
1.82
1.0
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
73
2.09
1.82
2.8
2.9
—
—
—
0
0
(4094501)
18
95
1.93
1.77
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
26
155
1.71
1.76
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
32
204
1.61
1.70
1.2
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
62
456
1.41
1.68
1.8
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
33
2.45
1.54
1.1
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
470
4520
1.41
1.53
12.7
10.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
65
2.03
1.50
1.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
28
2.52
1.45
1.7
1.3
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
16
3.14
1.44
1.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
16
3.14
1.44
1.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
16
3.14
1.44
1.0
3.7
u/l
176.4
203.7
—
5
16
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
22
2.75
1.44
1.0
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
39
2.33
1.43
3.4
3.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
46
2.20
1.40
1.0
2.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
17
96
1.80
1.40
1.1
1.1
u/ml
1.6
0.7
0.53
11
47
(21494755) Public health laboratory ask at order entry panel
38
531
0.69
1.38
1.3
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
23
2.63
1.37
1.2
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
38
266
1.46
1.36
1.9
1.4
iu/l
17.4
23.3
0.72
31
219
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
17
2.96
1.36
1.0
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
75
1.89
1.35
1.4
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
137
1596
0.81
1.35
2.8
2.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
37
0.00
1.35
0.0
3.5
—
19.0
—
0
26
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
105
1.74
1.35
1.9
2.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
132
1117
1.24
1.34
2.9
2.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
41
293
1.43
1.33
2.7
2.5
ml/min/173m2
75.2
72.5
0.14
17
119
(3049717) Cytology report of Urine Cyto stain
20
121
1.68
1.32
1.9
2.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
40
285
1.44
1.32
2.1
3.1
e9/l
60.0
71.0
1.57
28
221
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
50
371
1.38
1.32
4.3
2.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
43
2.11
1.31
1.1
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
160
1387
1.22
1.29
3.6
3.1
ng/l
23.4
42.8
1.67
87
869
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
69
1.91
1.29
1.2
1.3
nmol/l
0.6
0.5
0.38
13
64
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
18
2.79
1.28
1.0
1.6
—
—
—
0
0
(3010421) pH of Blood
15
84
1.81
1.28
4.1
2.7
ph
7.4
7.4
0.15
15
68
(3037121) Protein [Mass/volume] in Urine
24
154
1.59
1.28
1.6
3.6
g/l
0.1
0.2
0.95
11
68
(3003694) ABO and Rh group [Type] in Blood
150
1294
1.22
1.27
1.6
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
71
560
1.31
1.27
2.0
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
115
1.68
1.26
1.4
2.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
139
1.61
1.25
1.4
2.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
164
1430
1.21
1.25
9.8
7.8
inr
1.2
1.2
0.35
47
436
(3000991) Gas panel - Venous blood
42
308
1.40
1.20
4.4
9.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
98
813
1.25
1.19
1.9
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
64
1.90
1.19
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
64
1.90
1.19
1.2
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
38
2.12
1.19
1.0
2.9
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
14.2
—
915.9
—
0
33
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
18.6
—
1659.2
—
0
33
(3034770) Mitochondria Ab [Titer] in Serum
19
118
1.63
1.16
1.2
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
87
1.75
1.16
2.5
2.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
20
2.51
1.15
1.2
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
20
2.51
1.15
1.0
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
20
2.51
1.15
1.2
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
51
390
1.34
1.14
1.6
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
65
517
1.29
1.11
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
423
4050
1.24
1.11
4.4
4.1
mmol/l
5.7
5.8
2.28
386
3731
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
21
136
1.57
1.10
1.5
1.8
ug/l
0.8
3.4
0.68
16
123
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
81
1.75
1.10
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
41
1.97
1.09
1.8
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
32
2.20
1.08
1.1
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
59
1.88
1.08
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
37
273
1.38
1.04
1.5
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
34
2.07
1.03
1.0
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
15
91
1.67
1.01
1.1
1.1
u/ml
5.3
4.0
—
6
19
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
50
389
1.32
1.01
1.6
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
48
1.89
1.01
2.8
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
49
1.85
0.99
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
29
0.00
0.98
0.0
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
494
4836
1.41
0.97
22.3
17.4
e9/l
253.0
254.6
0.22
484
4713
(4306422)
10
54
1.87
0.97
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
31
0.00
0.96
0.0
2.5
—
3.6
—
0
13
(3015171) Extractable nuclear Ab [Units/volume] in Serum
24
166
1.47
0.96
1.1
1.2
—
2.8
—
0
10
(3022621) pH of Urine by Test strip
35
260
1.37
0.96
2.2
2.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
494
4838
1.41
0.95
22.3
17.4
e12/l
4.5
4.5
0.74
482
4701
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
27
2.24
0.93
1.0
1.5
g/l
0.8
1.0
—
6
27
(3024928) Oxygen saturation in Venous blood
12
70
1.73
0.93
1.8
8.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
52
1.74
0.92
1.0
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
494
4840
1.40
0.92
22.4
17.5
e9/l
6.5
6.7
0.64
483
4701
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
37
280
1.35
0.91
2.9
2.1
ug/l
4.1
7.9
1.20
29
250
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
17
111
1.55
0.88
1.3
2.2
mg/l
11.6
12.0
0.09
17
101
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
120
1.52
0.86
1.3
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
72
602
1.23
0.84
2.4
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
76
642
1.22
0.81
2.9
2.9
ug/l
0.5
0.7
3.94
58
405
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
34
1.77
0.76
1.5
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
99
1.53
0.76
1.2
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
29
219
1.34
0.75
2.1
2.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
5
24
2.09
0.74
1.2
1.0
ng/l
34.8
30.2
—
5
13
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
5
24
2.09
0.74
1.2
1.0
ng/l
401.0
225.7
—
5
13
(3002032) Base excess in Venous blood by calculation
42
335
1.28
0.74
3.2
5.5
mmol/l
1.1
2.1
1.22
35
265
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
55
1.65
0.74
5.7
2.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
38
1.85
0.73
1.1
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
114
1009
1.17
0.73
2.0
2.7
umol/l
309.5
7043.3
4.38
96
885
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
25
2.01
0.73
1.0
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
5
25
2.01
0.73
1.2
1.4
u/l
4.5
7.5
—
5
20
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
40
1.76
0.71
1.4
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
26
1.93
0.71
1.2
1.3
nmol/l
17.9
28.2
—
5
20
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
26
1.93
0.71
2.2
2.8
u/ml
325.6
648.1
—
5
26
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
41
1.72
0.70
1.3
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
93
1.52
0.70
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
196
1.34
0.69
1.8
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
170
1.37
0.68
1.3
1.4
miu/ml
316.0
254.9
—
10
89
(3042631) Mycobacterium sp identified in Specimen
7
42
1.68
0.68
2.1
2.7
—
—
—
0
0
(4027681)
5
27
1.86
0.68
1.8
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
62
1.62
0.65
2.0
8.2
%
54.3
62.9
—
10
62
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
44
1.60
0.65
1.0
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
190
1.33
0.64
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
25
190
1.33
0.64
1.3
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
96
1081
0.86
0.63
4.0
3.8
mg/mmol
8.6
10.3
0.14
62
676
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
49
1.64
0.62
1.3
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
191
1.32
0.62
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
25
191
1.32
0.62
1.4
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
50
1.61
0.61
1.4
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
50
1.61
0.61
1.4
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
14
198
0.70
0.61
4.1
9.0
mmol/l
23.2
24.5
0.59
14
189
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
17
122
1.41
0.60
1.5
1.7
—
226.7
—
0
6
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
21
0.00
0.60
0.0
1.6
—
6.5
—
0
21
(3009214) Lutropin [Units/volume] in Serum or Plasma
20
149
1.36
0.58
1.5
1.4
u/l
10.2
9.4
0.09
13
113
(3028707) Methadone [Presence] in Urine by Screen method
13
89
1.47
0.58
1.4
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
172
0.69
0.57
1.3
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
17
124
1.38
0.56
1.1
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
90
0.55
0.56
1.0
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
388
3759
1.13
0.55
4.9
5.1
mmol/mol
37.1
38.8
5.05
364
3521
(3003740) Influenza virus B Ag [Presence] in Specimen
12
82
1.47
0.54
1.3
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
82
1.47
0.54
2.1
1.6
pmol/l
184.9
238.1
0.68
12
75
(3002523) Influenza virus A Ag [Presence] in Specimen
12
82
1.47
0.54
1.3
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
53
452
1.19
0.54
1.6
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
42
500
0.83
0.54
3.7
4.1
%
31.9
31.1
0.27
33
336
(3005033) Fetal Nuchal fold Thickness US
21
160
1.33
0.54
1.4
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
30
369
0.80
0.53
6.0
9.2
kpa
4.8
5.2
1.05
30
357
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
161
1.32
0.52
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
96
0.62
0.52
11.8
4.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
17
225
0.75
0.52
6.3
9.4
%
1.3
1.4
0.22
17
225
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
17
225
0.75
0.52
6.8
9.4
%
0.9
0.7
0.66
17
225
(40761535) Cells panel - Urine sediment
36
297
1.23
0.52
2.8
3.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
61
530
1.17
0.51
2.0
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
30
367
0.81
0.51
5.9
9.2
mmol/l
0.6
1.2
0.49
24
301
(3040151) Glucose [Moles/volume] in Capillary blood
7
45
1.56
0.49
1.9
7.0
mmol/l
7.2
7.0
—
7
37
(3013512) EKG study
116
1060
1.12
0.48
3.1
3.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
26
321
0.80
0.48
5.7
9.8
g/l
124.2
121.0
0.28
26
312
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
47
1.50
0.47
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
47
1.50
0.47
1.0
1.5
—
—
—
0
0
(4034850)
10
141
0.70
0.45
5.6
7.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
28
339
0.82
0.44
5.4
9.6
%
96.1
96.0
0.09
28
331
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
26
211
1.24
0.44
1.5
1.9
mg/l
1.2
2.7
2.16
18
149
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
174
0.74
0.44
1.1
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
166
1.28
0.44
1.4
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
27
221
1.23
0.43
2.1
2.3
u/l
6919.1
2821.5
0.25
12
97
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
31
1.62
0.43
1.6
3.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
56
1.44
0.42
3.0
2.3
%
13.6
13.2
—
8
56
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
94
0.63
0.42
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
41
352
1.18
0.41
4.3
3.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
172
0.75
0.41
1.0
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
19
150
1.28
0.40
1.3
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
34
1.48
0.40
1.2
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
32
270
1.20
0.39
2.1
2.5
g/l
66.3
67.0
0.22
27
249
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
71
1.42
0.39
2.9
3.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
36
1.39
0.38
1.4
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
67
1.35
0.38
2.0
2.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
70
1.29
0.37
1.2
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
9
71
1.27
0.36
1.0
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
42
1.43
0.35
1.3
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
43
1.40
0.35
1.2
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
94
1017
0.91
0.35
3.0
3.1
mg/l
59.5
394.5
1.59
58
643
(3009508) Creatinine [Moles/volume] in Urine
109
1170
0.91
0.34
2.8
3.0
mmol/l
8.1
7.7
0.26
97
984
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
82
1.35
0.34
1.5
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
391
3991
0.92
0.34
3.7
3.6
mmol/l
1.1
1.3
5.97
365
3701
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
155
0.77
0.33
1.6
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
25
210
1.20
0.33
1.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
93
860
1.10
0.33
4.3
4.0
%
24.6
21.6
0.71
41
380
(3000764) Benzodiazepines [Presence] in Urine
25
211
1.19
0.32
1.4
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
211
1.19
0.32
1.4
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
106
989
1.09
0.31
4.0
4.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
46
410
1.13
0.31
22.3
20.5
inr
1.0
1.2
—
5
69
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
212
1.19
0.31
1.4
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
129
1.25
0.30
3.1
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
75
1.34
0.30
2.7
3.6
%
58.8
57.8
—
10
75
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
72
782
0.91
0.29
1.8
1.6
pmol/l
449.8
16941966.0
0.76
62
667
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
56
1.25
0.29
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
23
195
1.19
0.28
1.4
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
36
318
1.14
0.28
1.3
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
62
1.29
0.28
1.0
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
59
539
1.11
0.27
1.9
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
168
1.20
0.27
2.4
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
51
561
0.90
0.27
1.5
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
15
122
1.24
0.27
1.3
1.4
iu/ml
0.1
0.1
—
5
29
(3000330) Specific gravity of Urine by Test strip
22
187
1.18
0.27
6.8
3.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
206
1.17
0.26
1.5
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
71
0.70
0.26
4.0
4.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
72
0.69
0.26
1.2
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
74
1.22
0.25
2.8
3.2
e9/l
3.8
4.2
—
9
74
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
9
76
1.19
0.24
1.6
1.2
ug/l
3.4
2.7
—
9
68
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
77
1.17
0.24
1.3
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
38
1.32
0.23
7.0
3.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
162
1.18
0.23
1.5
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
97
1.24
0.23
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
39
1.28
0.23
1.4
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
79
1.27
0.22
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
86
913
0.93
0.22
3.5
3.3
kg/l
1.0
1.0
0.10
15
121
(40768795) Lymph node Pathology biopsy report
5
41
1.22
0.22
1.6
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
9.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
10
0.00
0.21
0.0
1.4
—
5.9
—
0
5
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
9.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
164
1579
1.06
0.21
4.0
3.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
19
164
1.16
0.20
1.9
4.7
%
0.7
0.7
0.06
19
159
(3020891) Body temperature
10
123
0.81
0.20
2.9
4.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
10
123
0.81
0.20
1.2
1.5
pmol/l
44.9
196.8
—
10
118
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
111
0.81
0.20
1.1
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.2
1.3
—
—
—
0
0
(3019225) pH of Specimen
39
356
1.10
0.19
4.8
4.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
90
1.23
0.19
1.3
1.4
—
—
—
0
0
(4268621)
6
52
1.16
0.19
2.0
2.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
59
1.19
0.18
1.0
1.3
nmol/l
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
224
1.12
0.17
1.2
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
245
0.89
0.16
2.4
2.4
u/ml
19.5
40.9
1.21
22
233
(3002179) Metamyelocytes/100 leukocytes in Blood
31
285
1.09
0.14
4.5
4.9
%
0.3
0.5
0.47
11
71
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
110
0.81
0.13
1.4
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
119
1153
1.04
0.12
3.8
3.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
179
0.89
0.12
6.9
12.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
18
199
0.90
0.11
3.2
7.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
26
240
1.09
0.11
2.6
3.6
mmol/l
2.1
1.8
0.15
19
170
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
410
4133
0.96
0.11
4.2
4.0
mmol/l
1.5
1.5
0.33
386
3846
(3021440) Promyelocytes/100 leukocytes in Blood
32
299
1.07
0.11
4.6
5.1
%
0.0
0.2
3.09
13
90
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
11
96
1.15
0.10
2.5
3.7
—
2.4
—
0
14
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
424
4210
1.04
0.10
4.8
4.5
mmol/l
2.8
2.8
0.19
401
3915
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
44
1.14
0.10
3.4
4.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
3.0
2.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
18
165
1.09
0.09
2.9
4.0
mmol/l
24.9
24.9
0.05
18
159
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
1.0
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
417
4144
1.03
0.08
4.2
4.0
mmol/l
4.6
4.7
0.91
395
3874
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.4
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
67
1.05
0.08
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
68
1.03
0.08
1.4
1.8
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
75
0.80
0.07
1.3
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
91
0.88
0.07
1.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
90
0.89
0.07
1.5
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
16
172
0.93
0.06
7.9
11.1
mmol/l
24.8
24.7
0.12
16
163
(3017181) Myelocytes/100 leukocytes in Blood
33
318
1.04
0.04
4.5
4.9
%
0.3
0.9
2.34
15
102
(3022313) Gas panel - Capillary blood
20
190
1.05
0.04
2.7
3.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
11
119
0.92
0.04
1.8
3.3
kpa
8.1
8.8
0.59
11
111
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
44
452
0.97
0.03
7.4
5.4
—
—
—
0
0
(3009343) pH of Capillary blood
26
250
1.04
0.03
2.7
3.5
ph
7.4
7.4
—
5
27
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
142
1.06
0.02
2.7
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
332
1.03
0.02
1.4
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
214
1.03
0.00
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
97
1.03
0.00
1.2
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
28
283
0.99
0.00
4.8
5.2
%
0.0
0.1
0.71
11
76
(3029937) Albumin [Presence] in Urine by Test strip
108
1075
1.01
0.00
4.0
3.5
estimate
0.0
0.0
0.88
40
390
(3050129) First trimester maternal screen panel - Serum or Plasma
22
222
0.99
0.00
1.2
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
106
1063
1.00
0.00
5.0
4.6
ug/l
1.5
2.6
2.16
99
950
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
62
0.97
0.00
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
56.2
—
0
6
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
61
0.98
0.00
1.3
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
52
0.96
0.00
3.0
1.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.3
—
1.2
—
0
8
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
2.3
—
7154.4
—
0
8
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
7.7
—
0
8
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
12.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3039000) Anion gap in Blood
7
73
0.96
0.00
4.3
12.7
mmol/l
10.6
11.1
—
7
66
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
7
73
0.96
0.00
4.3
12.7
mmol/l
105.3
105.0
—
7
66
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
1.4
—
1.2
—
0
9
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
94
0.96
0.00
1.8
2.5
mmol/l
25.1
24.9
—
9
83
(4010399)
28
280
1.00
0.00
1.5
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
52
0.96
0.00
1.0
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
21.5
—
0.4
—
0
8
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
7
0.00
0.00
0.0
1.0
—
3.3
—
0
7
(3044007) Cell count panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
66
0.91
0.00
1.5
1.9
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
-0.00
0.0
3.0
—
0.8
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
2.6
—
199.0
—
0
5
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
5
0.00
-0.00
0.0
1.4
—
35.4
—
0
5
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
-0.00
0.0
1.6
—
4.5
—
0
5
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
-0.00
0.0
3.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_PROTOZOAL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_PROTOZOAL | 1.862 [1.43, 2.42] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.498 |
During the follow-up period (1.1.1998 — 31.12.2019), 137 out of 1428 females with AB1_OTHER_PROTOZOAL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_PROTOZOAL | 1.772 [1.39, 2.27] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 128 out of 1146 males with AB1_OTHER_PROTOZOAL died.
Mortality risk
Mortality risk for people of age
years, who have AB1_OTHER_PROTOZOAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.177% | 0.302% |
| 5 | 1.094% | 1.879% |
| 10 | 2.787% | 4.981% |
| 15 | 5.699% | 9.485% |
| 20 | 9.974% | 15.868% |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_PROTOZOAL – Other protozoal intestinal diseases
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data